ACW actinogen medical limited

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-9

  1. 9,071 Posts.
    lightbulb Created with Sketch. 1476
    I agree that Dr Ketelbey is always careful to say "associated with", not "causes".

    I don't think it's productive to speculate precisely why a once daily low dose of a drug with a known half life of 10-14 hours failed to significantly improve cognition over placebo. Maybe the low dose and wrong frequency couldn't beat the powerful placebo? Better to just move on, as ACW is doing.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.6¢
Change
0.003(13.0%)
Mkt cap ! $82.60M
Open High Low Value Volume
2.4¢ 2.6¢ 2.4¢ $101.9K 4.001M

Buyers (Bids)

No. Vol. Price($)
3 1061873 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 315142 4
View Market Depth
Last trade - 16.10pm 17/07/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.